0 item(s) in My Cart

Common Anti-cancer Therapies

Common Anti-cancer Therapies

Common Anti-cancer Therapies

Item No.

Buy Box
  1. Availability:
    In Stock
  2. Availability:
    Usually ships in 1 to 2 days
Not yet rated. Be the first to write a review

Product Details

Designed for those preparing for an exam or looking for a refresher, this course offers a review of the general principles of anti-cancer therapies for the most common cancers in the US: colorectal, prostate, breast and lung. The learner will apply knowledge of the stages of diagnosis that are most common, the therapies associated with each as well as the treatment related side effects/risks associated with specific chemotherapy treatments. Breast treatment will cover endocrine therapy, aromatase inhibitors and tamoxifen; colorectal treatment outlines FOLFOX, CapOx and 5-FU; prostate treatment details cover LHRH antagonists, anti-androgens; and lung treatment covers Crizotinib, Erlotinib, Gefitinib, Carboplatin and Paclitaxel.


  • Shipping charges do not apply to digital products. Any charges applied will be refunded during checkout as a rebate. To access your product, log on to asco.org/activate. Enter the activation code provided in a separate email from ascopubs@asco.org.

    Offer Details
    Here's how (restrictions apply).
Customer Reviews

No reviews yet. Be the first to write a review